Grants for Innovative Treatment, Vaccine or Microbicide Research, Application Deadline July 31
June 12, 2004
GlaxoSmithKline will award a total of $250,000 for innovative HIV/AIDS treatment, vaccine, or microbicide drug discovery and development research (from $25,000 to $150,000 for each grant). Researchers must submit applications by July 31, 2004 and the grants will be paid on December 1. There is no obligation to license resulting technology to the company.
In the previous three years of the program, GSK has awarded $1.25 million to 14 researchers.
For more information about the GSK Drug Discovery and Development Research Grant Program, and for an application, call 1-888-527-6935 or visit www.dddresearchgrant.com.
This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News.